$CTNM 3 SEC Filings

Filed On	Filing
28 Apr 2025	Form 3: Watkins Tim, CMO & Head of Development No securities owned
17 Mar 2025	Form 3: Miralles Gines Diego, Director
24 Jun 2024	Form 3: Boyce Sarah, Director No securities owned
03 Jun 2024	Form 3: Healy John Stephen, General Counsel and Corp Sec No securities owned
20 May 2024	Form 3: Ignelzi Troy A., Director No securities owned
10 Apr 2024	Form 3: Johnson & Johnson, 10% owner and 1 other Holds 1,979,173 shares of Class A Common Stock
04 Apr 2024	Form 3: Versant Venture Capital VI, L.p., 10% owner and 8 others Holds 375,535 shares of Class A Common Stock
04 Apr 2024	Form 3: Ware Olivia C, Director
04 Apr 2024	Form 3: Schimmelpennink Evert B., Director
04 Apr 2024	Form 3: Lyons-Williams Lori, Director
04 Apr 2024	Form 3: Brady Todd R., Director
04 Apr 2024	Form 3: Huhn Stephen L., CMO & Sr VP, Clinical Dev.
04 Apr 2024	Form 3: Slover Peter T, Chief Financial Officer
04 Apr 2024	Form 3: Lorrain Daniel S., Chief Scientific Officer Holds 175,762 shares of Class A Common Stock
04 Apr 2024	Form 3: Stengone Carmine N., Director Holds 11,612 shares of Class A Common Stock

Comments